Jianguang Liu

Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial

Shengyuan Yu, Byung‐Kun Kim, Aihong Guo et al. · The Lancet Neurology · 2023 · 66 citations

Cluster Headache, South Korea, Medicine +5

Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019

Qiuxiang Yang, Ling Xie, Wei Zhang et al. · Journal of Clinical Pharmacy and Therapeutics · 2020 · 53 citations · Full text

Quercetin regulates inflammation, oxidative stress, apoptosis, and mitochondrial structure and function in H9C2 cells by promoting PVT1 expression

Fen Li, Jianguang Liu, Shifan Tang et al. · Acta Histochemica · 2021 · 48 citations · Full text

Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial

Shengyuan Yu, Aihong Guo, Zhen Wang et al. · The Journal of Headache and Pain · 2024 · 26 citations · Full text

Quercetin Protects H9c2 Cardiomyocytes against Oxygen-Glucose Deprivation/Reoxygenation-Induced Oxidative Stress and Mitochondrial Apoptosis by Regulating the ERK1/2/DRP1 Signaling Pathway

Fen Li, Dongsheng Li, Shifan Tang et al. · Evidence-based Complementary and Alternative Medicine · 2021 · 16 citations · Full text